{
  "abstract": "Severe asthma is now regarded as ‘too-late’ asthma, reflecting missed opportunities for early intervention and prevention.1 The focus of asthma care is shifting towards early identification of individuals at risk of adverse outcomes, a strategy that is critical to reducing oral corticosteroid exposure, hospital admissions and asthma-related death.",
  "authors": [
    {
      "affiliations": [
        "Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, UK",
        "NIHR-Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK"
      ],
      "name": "Ran Wang"
    },
    {
      "affiliations": [
        "Centre for Medical Informatics, University of Edinburgh Division of Medical and Radiological Sciences, Edinburgh, UK"
      ],
      "name": "Luke Daines"
    },
    {
      "affiliations": [
        "Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, UK",
        "NIHR-Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK"
      ],
      "name": "Stephen J Fowler"
    }
  ],
  "title": "Preventing severe asthma exacerbations in at-risk patients: time for a rethink",
  "uid": "4f959c86-1831-5553-8f3b-b6bb6df4906a"
}